Literature DB >> 23506866

SLC6 transporters: structure, function, regulation, disease association and therapeutics.

Akula Bala Pramod1, James Foster, Lucia Carvelli, L Keith Henry.   

Abstract

The SLC6 family of secondary active transporters are integral membrane solute carrier proteins characterized by the Na(+)-dependent translocation of small amino acid or amino acid-like substrates. SLC6 transporters, which include the serotonin, dopamine, norepinephrine, GABA, taurine, creatine, as well as amino acid transporters, are associated with a number of human diseases and disorders making this family a critical target for therapeutic development. In addition, several members of this family are directly involved in the action of drugs of abuse such as cocaine, amphetamines, and ecstasy. Recent advances providing structural insight into this family have vastly accelerated our ability to study these proteins and their involvement in complex biological processes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23506866      PMCID: PMC3602807          DOI: 10.1016/j.mam.2012.07.002

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  151 in total

Review 1.  Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Authors:  John Grabowski; James Shearer; John Merrill; S Stevens Negus
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

2.  Identification of a chloride ion binding site in Na+/Cl -dependent transporters.

Authors:  Lucy R Forrest; Sotiria Tavoulari; Yuan-Wei Zhang; Gary Rudnick; Barry Honig
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

3.  Identification of a testis-expressed creatine transporter gene at 16p11.2 and confirmation of the X-linked locus to Xq28.

Authors:  G S Iyer; R Krahe; L A Goodwin; N A Doggett; M J Siciliano; V L Funanage; R Proujansky
Journal:  Genomics       Date:  1996-05-15       Impact factor: 5.736

4.  Motor activity and rotational behavior after analogs of cocaine: correlation with dopamine uptake blockade.

Authors:  R E Heikkila; F S Cabbat; R C Duvoisin
Journal:  Commun Psychopharmacol       Date:  1979

5.  Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.

Authors:  Takato Hiranita; Paul L Soto; Stephen J Kohut; Theresa Kopajtic; Jianjing Cao; Amy H Newman; Gianluigi Tanda; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2011-08-22       Impact factor: 4.030

6.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

7.  Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes.

Authors:  Britta Haenisch; Karoline Linsel; Michael Brüss; Ralf Gilsbach; Peter Propping; Markus M Nöthen; Marcella Rietschel; Rolf Fimmers; Wolfgang Maier; Astrid Zobel; Susanne Höfels; Vera Guttenthaler; Manfred Göthert; Heinz Bönisch
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-10-05       Impact factor: 3.568

Review 8.  Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic--A focus on analogues of benztropine and rimcazole.

Authors:  Amy Hauck Newman; Santosh Kulkarni
Journal:  Med Res Rev       Date:  2002-09       Impact factor: 12.944

9.  Influence of early stress on social abilities and serotonergic functions across generations in mice.

Authors:  Tamara B Franklin; Natacha Linder; Holger Russig; Beat Thöny; Isabelle M Mansuy
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

10.  Molecular basis of alternating access membrane transport by the sodium-hydantoin transporter Mhp1.

Authors:  Tatsuro Shimamura; Simone Weyand; Oliver Beckstein; Nicholas G Rutherford; Jonathan M Hadden; David Sharples; Mark S P Sansom; So Iwata; Peter J F Henderson; Alexander D Cameron
Journal:  Science       Date:  2010-04-23       Impact factor: 47.728

View more
  90 in total

1.  Environmental enrichment enhances synaptic plasticity by internalization of striatal dopamine transporters.

Authors:  Myung-Sun Kim; Ji Hea Yu; Chul Hoon Kim; Jae Yong Choi; Jung Hwa Seo; Min-Young Lee; Chi Hoon Yi; Tae Hyun Choi; Young Hoon Ryu; Jong Eun Lee; Bae Hwan Lee; Hyongbum Kim; Sung-Rae Cho
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-02       Impact factor: 6.200

2.  Trimerization of dopamine transporter triggered by AIM-100 binding: Molecular mechanism and effect of mutations.

Authors:  Mary Hongying Cheng; Luca Ponzoni; Tatiana Sorkina; Ji Young Lee; She Zhang; Alexander Sorkin; Ivet Bahar
Journal:  Neuropharmacology       Date:  2019-06-20       Impact factor: 5.250

Review 3.  Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops.

Authors:  George Khelashvili; Harel Weinstein
Journal:  Biochim Biophys Acta       Date:  2015-04-04

4.  Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics.

Authors:  Ara M Abramyan; Rachel D Slack; Sitaram Meena; Bruce A Davis; Amy Hauck Newman; Satinder K Singh; Lei Shi
Journal:  Neuropharmacology       Date:  2018-11-01       Impact factor: 5.250

5.  Taurine Transporter dEAAT2 is Required for Auditory Transduction in Drosophila.

Authors:  Ying Sun; Yanyan Jia; Yifeng Guo; Fangyi Chen; Zhiqiang Yan
Journal:  Neurosci Bull       Date:  2018-07-24       Impact factor: 5.203

6.  Neurotransmitter and psychostimulant recognition by the dopamine transporter.

Authors:  Kevin H Wang; Aravind Penmatsa; Eric Gouaux
Journal:  Nature       Date:  2015-05-11       Impact factor: 49.962

7.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 8.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

9.  miR-137 and miR-491 Negatively Regulate Dopamine Transporter Expression and Function in Neural Cells.

Authors:  Xiaojian Jia; Feng Wang; Ying Han; Xuewen Geng; Minghua Li; Yu Shi; Lin Lu; Yun Chen
Journal:  Neurosci Bull       Date:  2016-09-15       Impact factor: 5.203

10.  The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport.

Authors:  Bruce Felts; Akula Bala Pramod; Walter Sandtner; Nathan Burbach; Simon Bulling; Harald H Sitte; L Keith Henry
Journal:  J Biol Chem       Date:  2013-11-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.